Physicians Eager To Increase Their First- And Second-Line Prescriptions For Januvia Over The Next Two Years For The Treatment Of Type 2 Diabetes

 05.09.2008 06:17   medicalnewstoday.com

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Merck's Januvia is currently prescribed most often as a third- or later-line of therapy for the treatment of type 2 diabetes.

World Diabetes